COMP <GO>
AKAM vs PG // ALTMAN Z-SCORE & DEBT/EQUITY
Akamai Technologies Inc. (NASDAQ) VS. Procter & Gamble Company (The) (NYSE) • 15-METRIC TALLY: AKAM 6
— PG 9
▲ ALTMAN Z-SCORE & DEBT/EQUITY LEADER: PG
LAST: $92.72 (-6.70%) • MKT CAP: $14.28B
balance-sheet
2.38
LAST: $161.57 (+0.61%) • MKT CAP: $372.21B
balance-sheet
5.59
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AKAM VS. PG)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AKAM | PG | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 56.80% | 51.20% | +5.60 | AKAM | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.60% | 25.40% | -18.80 | PG | /roic <GO> |
| EV/EBITDA & P/E Valuation | 16.1x | 16.2x | -0.10 | AKAM | /valuation <GO> |
| Free Cash Flow Yield | 7.08% | 3.77% | +3.31 | AKAM | /fcf-yield <GO> |
| Operating Margin | 14.20% | 24.30% | -10.10 | PG | /operating-margins <GO> |
| Net Profit Margin | 11.30% | 19.00% | -7.70 | PG | /net-margins <GO> |
| Revenue Growth (YoY) | 7.70% | 0.30% | +7.40 | AKAM | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.65% | -2.65 | PG | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity ACTIVE | 2.38 | 5.59 | -3.21 | PG | /balance-sheet <GO> |
| Piotroski F-Score Quality | 8/9 | 7/9 | +1.00 | AKAM | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.10% | 6.50% | +0.60 | PG | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.1 | 62.7 | -21.55 | PG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.06 | 0.87 | +0.19 | AKAM | /macro-sensitivity <GO> |
| Forward P/E Multiple | 29.4x | 21.7x | +7.70 | PG | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $14.28B | $372.21B | -$357.93B | PG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AKAM REV | PG REV | AKAM GROSS % | PG GROSS % | AKAM FCF | PG FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $0 | $84.28B | — | 51.2% | $1.01B | $14.04B |
| FY 2024 | $0 | $84.04B | — | 51.4% | $1.13B | $16.52B |
| FY 2023 | $0 | $82.01B | — | 44.0% | $1.35B | $13.16B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AKAM // BETA 1.06
PG // BETA 0.87